More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.
Tian M, Liang X, Xu W, Yi X, Yue T, Zhang Y, Yu S, Yan Y, Hu Z, Zhang N, Wang J, Hu R, Sun X, Nie Y, Dai Y, Jin F.
Tian M, et al. Among authors: zhang n, zhang y.
Ann Hematol. 2023 Oct;102(10):2943-2945. doi: 10.1007/s00277-023-05362-8. Epub 2023 Jul 12.
Ann Hematol. 2023.
PMID: 37434095
No abstract available.